Connor, Clark & Lunn Investment Management Ltd.

Position in BIO — Bio-Rad Laboratories, Inc.

CIK 1596800 VANCOUVER, A1

Position in BIO

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$449,810

-$680,222 QoQ

Shares Held

1,532

-43.4% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#214

of 397 holders

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $204,731,115 across 26 Medical Devices names. BIO ranks #18 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	869,131	$78,864,946
2	BSX	Boston Scientific Corp	1,467,148	$62,617,875
3	PHG	Koninklijke Philips NV	563,724	$15,327,654
4	SNN	Smith & Nephew PLC	487,774	$14,052,767
5	NVCR	NovoCure Ltd	661,280	$10,018,391
6	IRTC	iRhythm Holdings, Inc.	42,314	$5,033,250
7	AXGN	Axogen, Inc.	67,118	$3,100,180
8	VREX	Varex Imaging Corp	293,435	$3,060,526

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$449,810	1,532	-43.4%	Shares	Sole	2026-08-13
2022-09-30	$1,130,032	2,709	+68.3%	Shares	Sole	2022-11-10
2022-06-30	$796,950	1,610	-37.2%	Shares	Sole	2022-08-05
2021-12-31	$1,935,770	2,562	-36.2%	Shares	Sole	2022-02-10
2021-09-30	$2,996,481	4,017	-53.5%	Shares	Sole	2021-11-12
2021-03-31	$4,933,195	8,637	-24.0%	Shares	Sole	2021-05-13
2020-12-31	$6,628,610	11,371	-28.0%	Shares	Sole	2021-02-16
2020-09-30	$8,141,175	15,794	+30.2%	Shares	Sole	2020-11-12
2020-06-30	$5,476,573	12,130	-44.2%	Shares	Sole	2020-08-13
2020-03-31	$7,624,680	21,750	—	Shares	Sole	2020-05-13
No filing history on record for this holder in this stock.